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Abstract
Ethnopharmacological relevance: Herbal medicinal products based on ginkgo leaf refined dry 
extract (GBE) are an European development from the Eastern Asia traditionally used species 
Ginkgo biloba L. Nowadays, ginkgo products have increased the presence in the market, mainly 
as dietary supplements. Its adulteration with rutin and quercetin or herbal extracts rich in these 
compounds is a common practice. Tests featuring assays and detection of adulterants need to be 
performed on top of other existent methods (e.g. identification test). This may increase the costs 
of evaluating the quality of ginkgo products.
Aim of the study: To prove that comprehensive HPTLC fingerprinting can provide information 
beyond identification of ginkgo products, avoiding additional chromatographic tests for detection 
of adulterations. 
Materials and methods: The information contained in the fingerprint obtained by HPTLC analysis 
of flavonoids was used for identification and for detection of adulterants, as well as to verify the 
limits of rutin and quercetin, which are normally determined by HPLC and used for detection of 
adulterants. For this purpose, peak profiles were generated from HPTLC chromatogram images. 
USP-HPLC methods were used for quantification of total flavonoids and testing the limits of rutin 
and quercetin. HPLC data were used to support the validity of the HPTLC method. An additional 
reversed phase HPTLC method was developed as a possible confirmatory method for the quercetin 
limit test.
Results: The proposed HPTLC method uses  a particular sequence of detections, resulting in a 
number of images, which are later interpreted in a certain order.  It is able to identify ginkgo 
products, to detect adulterants (rutin, quercetin, sophora fruit and flower bud, and buckwheat), and, 
using peak profiles generated from the chromatogram images prior to and after derivatisation, to 
evaluate the limits of rutin and quercetin. Forty-eight out of fifty-nine ginkgo dietary supplements 
analysed contained one or more adulterants. Furthermore, results of the HPTLC and HPLC limit 
tests for rutin and quercetin were in agreement in 98% of the cases. Finally, a decision tree showing 
the sequence of interpretation of the fingerprints obtained with the different detections after a single 
HPTLC analysis is included to help the analyst to evaluate whether samples have the correct 
identity and whether they contain or not adulterants.
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Conclusion: A single HPTLC analysis is able to provide information on identity and purity of the 
products. This simplifies the analytical workflow and reduces the number of analyses prescribed 
in the USP powdered ginkgo extract monograph.
Keywords: HPTLC; Ginkgo biloba L.; comprehensive HPTLC fingerprinting; identity; 
adulteration, dietary supplements;
ABBREVIATIONS
BWH: Buckwheat herb 
GBE: Ginkgo leaf refined dry extract
GBL: Ginkgo leaf
GP: Ginkgo product
HPTLC: High-Performance Thin-Layer Chromatography
I: Isorhamnetin
K: Kaempferol
NLT: Not less than
NP: Natural products reagent
PEG: Polyethylene glycol reagent
Q: Quercetin
SST: System suitability test
SJfr: Sophora fruit
SJfl: Sophora flower bud
USP: United States Pharmacopeia
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1. Introduction
Ginkgo (Ginkgo biloba L.), considered a sacred tree in the Eastern Asia, is traditionally associated 
with longevity. The earliest known medicinal use of ginkgo dates back to 2800 BC and it is 
described for the pseudofruits, which are more frequently used than leaves in Eastern Asia. 
However, based on some not very well documented uses in traditional Chinese medicine (TCM), 
a German company developed a medicinal product from leaves for cognitive impairment in 
dementia. The active ingredient is a ‘special’ extract – extract G. biloba (EGb) 761 –obtained by a 
water-acetone extraction and subsequent purification (Heinrich, 2010, Drieu and Jaggy, 2000). 
This ginkgo leaf refined dry extract (GBE), which uses 50 kg of leaf to yield 1 kg of extract, is 
standardized to contain 22-27% of flavonol glycosides and 5.4-6.6% of terpene lactones (EDQM, 
2018), and it is accepted for the improvement of age-associated cognitive impairment and of 
quality of life in mild dementia (European Medicines Agency, 2015). EGB products (with EGb 
761 and other similar refined extracts), that nowadays are in the market either as medicinal 
products or as dietary supplements, are in high demand. The global trade of gingko leaf extracts 
has registered a consistent growth in the last years. However, to produce such extract, about 19 
steps are involved with costs estimated at $200-250/Kg (Gafner, 2018, Czigle et al., 2018). 
Because of the complexity and high cost of the manufacturing process, adulteration of ginkgo 
products (GP) has become an important problem in poorly regulated markets. Booker et al. (2016) 
evaluated the quality of GP sold as food supplements in the UK, revealing that the majority of the 
samples (32 out of 35) showed a HPTLC fingerprint different from that described in the European 
Pharmacopoeia and US Pharmacopoeia. It was hypothesized they were adulterated with rutin, 
quercetin, and other botanical materials. One sample was found to contain only 5-
hydroxytryptophan.
According to Gafner (2018), industry experts agree that adulteration of GP often stems from 
economic considerations. Several publications report the addition of flavonol aglycones quercetin 
and/or kaempferol and/or the flavonol glycoside rutin to ginkgo products. Such practice is 
performed to ensure that those products, containing less extract, will have higher levels of total 
flavonoids after hydrolysis (22-27%) and thus comply with the HPLC assay specifications of the 
Pharmacopoeias (The United States Pharmacopoeia (USP), 2016b). The assay is based on the 
hydrolysis of the glycosides and the quantification of the resulting aglycones. Consequently, other 
botanical material, rich in glycosides of the same flavonol aglycones have also been reported as 
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adulterants. They are sophora fruit and flower bud (Styphnolobium japonicum (L.) Schott, syn: 
Sophora japonicum L.) and buckwheat herb (Fagopyrum sp Moench) (Avula et al., 2015; Chandra 
et al., 2011; Franz et al., 2011; He and Roller, 2011; Lopez-Gutierrez et al., 2016; Ma et al., 2016; 
Tawab et al., 2010; Wohlmuth et al., 2014; Yang et al., 2016, Gafner, 2018). 
Due to the lack of specificity to detect adulterants of the flavonoid-based assays, several 
publications propose additional methods, using different chromatographic techniques and 
detections (López-Gutiérrez et al., 2016, van Beek and Montoro, 2009). Since 2015, the United 
States Pharmacopoeia (USP) introduced an additional HPLC limit test for rutin and quercetin to 
the ginkgo extract monograph (The United States Pharmacopoeia (USP), 2016b). As acceptance 
criteria, the test solution (prior to hydrolysis) should not contain more than 4% of rutin and 0.5% 
of quercetin. As both substances have very different polarities, a gradient elution system over 1 
hour is needed. To perform all tests for identity, purity, and strength according to USP, five 
different analyses (including HPTLC and HPLC) featuring five different sample preparations, to 
analyse three classes of compounds are required. However, if identification is performed by 
HPTLC based on the “comprehensive HPTLC fingerprinting” concept (Frommenwiler et al., 
2018), more information can be obtained in a single analysis, and so avoid one HPLC test for 
purity.
In this paper we aim at further developing and illustrating how HPTLC fingerprints can be 
generated primarily for identification, in order to deliver additional information regarding the 
presence of adulterants and specifically the content of rutin and quercetin in ginkgo products. For 
detection of adulterants, different derivatisation steps and detection modes are considered. 
Additionally, quantitative information of the profiles generated from the images are used to verify 
compliance with the limit test for rutin and quercetin. The generated data are compared to those 
obtained by HPLC. A decision-tree detailing how best to perform comprehensive HPTLC 
fingerprinting for identification and detection of adulterations in gingko products is proposed.
2. Experimental
2.1. Samples and reference substances
Fifty-nine products of Ginkgo, including tablets, capsules, and soft gel capsules (GP1-PG59), sold 
as food supplements or medicines were used in the present work. They declared to contain either 
refined extracts (22-27% of flavonol glycosides), extracts with either DER 50:1 or no additional 
Arruda Frommenwiler et al. (revised) J. Ethnopharmacol.
6
information, powdered leaf, extract and leaf, extract and rutin, or extract and green buckwheat. A 
detailed description of the samples is presented in the supplementary information, Table S1.
Ginkgo leaf reference extracts (GBE) were obtained from Sigma/HWI (Darmstadt, Germany) and 
Dr. Willmar Schwabe (Karlsruhe, Germany). A sample of ginkgo leaf (GBL) was provided by the 
American Herbal Products Association (AHPA, Silver Spring, MD, USA). Botanical reference 
material of sophora fruit and flower bud were obtained from American Herbal Pharmacopoeia 
(AHP, Scotts Valley, USA). Buckwheat herb (batch 155239) was obtained from Chrüterhüsli 
(Basel, Switzerland). The standards genistein (99%), quercetin (99.5%) and rutin (91.3%) were 
obtained from USP (Rockville, USA). Kaempferol (97%) was obtained from Sigma (Darmstadt, 
Germany) and USP. Isorhamnetin (99%) from Extrasynthese (Genay, France) and USP.
2.2.  Reagents and solvents
Polyethylene glycol 400 (99.5%), 2-aminoethyldiphenylborinate (96.5%), acetic acid (99.5%), 
toluene (≥99%), acetone (pure), dichloromethane (HPLC grade), sodium acetate anhydrous 
(99.5%) and acetic anhydride (98.5%) were purchased from Merck (Darmstadt, Germany). 
Methanol (HPLC grade) and ortho-phosphoric acid (85%) were purchased from Carl Roth GmbH 
(Karlsruhe, Germany). Acetonitrile (HPLC grade), ethyl acetate (99.5%), formic acid (≥98%), 
tetrahydrofuran (extra pure) and p-anisaldehyde (≥99%) were purchased from Acros (New Jersey, 
USA). Ethanol (99.9%) was purchased from Alcosuisse (Bern, Switzerland). Deionized water was 
generated in-house. For the HPLC analysis, methanol, acetonitrile (both HPLC gradient grade) and 
hydrochloric acid (37%) were purchased from Fisher Scientific (Hamptom, USA). Phosphoric acid 
(≥85%) was obtained from Honeywell (New Jersey, USA), and formic acid (98-100%) from 
Scharlau (Barcelona, Spain).
2.3.  Instruments
A CAMAG HPTLC system controlled by visionCATS software and including Visualizer, 
Automatic TLC Sampler 4, Automatic Developing Chamber 2, TLC Plate Heater III and 
Chromatogram Immersion device was used. 
For the HPLC analysis, a Shimadzu instrument of the UFLC series c including auto sampler SIL-
20AC HT, pumps LC-20AD, degasser DGU-20As, column oven CTO-20A, diode array detector 
SPD-M20A, Phenomenex Gemini® NX C18 (100 Å, 5 μm, 4.6 mm × 250 mm) column and 
communication bus module CBM-20A was used. The software was LC Solutions (Shimadzu 
Corporation) version 1.23 SP1.
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2.4.  High performance thin layer chromatography (HPTLC)
HPTLC parameters for plate layout, sample application, conditioning of the plate, plate 
development and visualization were in agreement with the USP general Chapter <203> (The 
United States Pharmacopoeia (USP), 2017). The quality of the chromatography was verified based 
on the position of two or three standards, used as system suitability test (SST). The image’s 
background normalization was adjusted over the SST. 
2.4.1. Standard solutions
Solutions of rutin, chlorogenic acid, and quercetin were prepared at concentration of 0.2 mg/mL 
in methanol for the SST. For the limit test of rutin, the standard solution was prepared at 0.4 mg/mL 
of rutin in methanol. For the quercetin limit test based on a reference extract (Sigma/HWI GBE 
was used in this case), the weight of extract was adjusted to yield a solution (in methanol) 
representing 0.5% of quercetin in the extract. For the limit test of quercetin on reversed phase, the 
standard solution was prepared at 0.05 mg/mL of quercetin in methanol.
2.4.2. Test solutions
Sample of gingko leaf and products containing leaf were prepared according to the USP Ginkgo 
monograph (The United States Pharmacopoeia (USP), 2016a). Products containing ginkgo extract 
(capsules, soft gel capsules and tablets) were prepared to contain 10 mg of extract per mL of 
methanol, sonicated for 10 minutes at room temperature and centrifuged for 5 minutes at 5000 
rpm. Products containing leaf plus extract were processed as leaf, taking in account the labelled 
content of extract  and the drug-extract ratio, which were used to calculate its equivalence as leaf.
2.4.3. Chromatography 
The HPTLC method used for evaluating the samples was based on the USP ginkgo and powdered 
ginkgo extract monographs (The United States Pharmacopoeia (USP), 2016a and 2016b). The 
parameters for application volume, detection and derivatisation methods were optimized (see 
parameters described under HPTLC ID method in Table 1). A confirmatory additional method for 
the limit of quercetin was developed using a reversed phase plate (parameters are also described 
in Table 1).
Table 1. 
Parameters for the two HPTLC methods used in the present work.
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Parameters ID method Limit of quercetin (reversed phase)
Stationary phase 20x10cm plates Si 60 F254 (Merck) 20x10cm plates Si 60 RP-18 W (Merck)
SST
0.2 mg/mL of rutin, quercetin and chlorogenic acid 0.2 mg/mL of rutin and quercetin 
Preparation of 
standards for limit test
0.4 mg/mL (rutin, limit test) 0.05 mg/mL (quercetin, limit test)
Application volume 3 μL of test and standards solutions 3 μL of test and standards solutions
Developing solvent Ethyl acetate, acetic acid, formic acid, water 
(100:11:11:26 V/V/V/V)
ACNa, THFb and 0.5%H3PO4 aqueous solution 
(10:40:50 V/V/V)
Development 20 min saturation, 10 min conditioning at 33% 
relative humidity (with MgCl2), 70 mm distance 
from lower edge, room temperature = 23-27 ⁰C
20 min saturation, 10 min conditioning at 33% 
relative humidity (with MgCl2), 70 mm distance 
from lower edge, room temperature = 23-27 ⁰C
Documentation prior 
to derivatisation
UV 254 nm, UV 366 nm Not applicable
Derivatisation 1 Plates were heated at 100 ⁰C for 3 min and 
derivatised by dipping (speed: 3, time: 0) in NP 
reagent and then in PEG reagent
Plates were heated at 100 ⁰C for 3 min and 
derivatised by dipping (speed: 3, time: 0) in NP 
reagent and then in PEG reagent
Derivatisation 2 Plates were heated at 100 ⁰C for 3 min and 




derivatisation 1 or 2
UV 366 nm UV 366 nm
Derivatisation 3 Plates were dipped (speed: 3, time: 0) in p-





White light Not applicable
aACN: acetonitrile; bTHF: tetrahydrofuran; 
2.4.4. Derivatisation reagents
Natural products reagent (NP) was prepared dissolving 1 g of 2-aminoethyl diphenylborinate in 
200 mL of ethyl acetate. As a polyethylene glycol reagent (PEG) a dissolution of 10 g of 
polyethylene glycol 400 in 200 mL of dichloromethane was used. Finally, the anisaldehyde reagent 
was obtained dissolving 1 mL of p-anisaldehyde in 200 mL of a mixture of methanol, acetic acid 
and sulphuric acid (170:20:10 V/V/V).
2.4.5. Generation of peak profiles from chromatogram images
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Where necessary, the visionCATS software was used to generate peak profiles from fingerprints 
by calculating the luminance as L = (1/3 R)+(1/3 G)+(1/3 B) from the average of red (R), green 
(G), and blue (B) pixels of each line of the track and then plotting it against the RF values 
(Frommenwiler et al., 2018).
2.4.6. Limit tests of rutin and quercetin
Peak profiles were used for performing the limit tests of rutin and quercetin. Detections under UV 
254 nm prior to derivatisation (rutin) and under UV 366 nm after derivatisation with NP or NP 
plus PEG (quercetin) were used. Calculations were based on the peak heights at the position of 
rutin or quercetin in the samples and the standard solutions. Standard solutions at concentrations 
corresponding to the maximum limit accepted for rutin and quercetin according to USP powdered 
ginkgo extract monograph were used.
2.4.7.  Validation of the limit test of rutin and quercetin using the HPTLC ID method 
The analytical procedure, presented in this research has been validated in order to confirm its 
reliability. Linearity was established for rutin, based on the peak area of the peak profile under UV 
254 nm prior to derivatisation. Six data points in the range of 0.75–1.8 μg/application with 0.15 
and 0.3 μg intervals were used. The correlation coefficient (R2) was 0.999050 and the coefficient 
of variation (CV) was 0.88%. For quercetin, an extract was used to build the calibration curve. The 
peak heights of the peak profile under UV 366 nm after derivatisation were used. Linearity of the 
zone at the position of quercetin was established using six data points in the range of 0.06– 
0.21 μg/application of quercetin with 0.03 μg intervals, using GB reference extract with known 
content of quercetin (0.297%). The correlation coefficient (R2) was 0.999223 and the coefficient 
of variation (CV) was 1.51%.  For intraday and interday precision, one GB reference extract was 
prepared 4 times (each day), and solutions were analysed twice (2 plates per day). The absolute 
area of the peak at the position of rutin (under UV 254 nm prior after derivatization) and absolute 
height of the peak at the position of quercetin (under UV 366 nm prior to derivatization) in GB 
extract was used for the precision test. The intraday CV% was 2.08 for rutin and 0.89 for quercetin. 
The interday CV% was 3.48 for rutin and 2.65 for quercetin.
2.5.  High performance liquid chromatography (HPLC)
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The HPLC assay of total flavonoids was performed according to the USP powdered ginkgo extract 
monograph (The United States Pharmacopoeia (USP), 2016b) with all samples that declare to 
contain GBE. Samples that contain leaf were analysed according to its specific monograph. For 
tablets and capsules, an initial weight equivalent to 300 mg of extract was used. Additionally, the 
specific tests (limit of rutin and quercetin) according to USP powdered ginkgo extract monograph 
were applied for products containing refined extracts or other extracts. For products containing 
ginkgo leaf or mixtures of extracts with ginkgo leaf, rutin or buckwheat, this limit test was not 
performed. For tablets and capsules, an initial weight equivalent to 100 mg of extract was used. 
For both, assay and limit tests, each sample was prepared and analysed in duplicate. 
3. Results and discussion
In the current study, thirty-five ginkgo products obtained in the UK and twenty-four other products 
from other countries were analysed particularly for their purity. In addition to the detection 
prescribed in the identification section of the monographs, other detections were used (UV 254 nm 
and 366 nm prior to derivatisation). Those multiple images, generated during the identification 
test, are available for each analysis. HPTLC fingerprints and results for identity and adulteration 
of all samples are presented in the supplementary information (Figs. S1-S4, Table S2). In a first 
set of experiments, fifty-nine samples of ginkgo products were evaluated with the HPTLC ID 
method. Their fingerprints were compared to the description of the monograph and to reference 
materials of ginkgo leaf and extract. Typical fingerprints are shown in Fig. 1. It was observed that 
only eleven samples were compliant with the monograph description. 
Under UV 254 nm prior to derivatisation (Fig. 1), several products show intense quenching zones 
at the position of rutin (e.g. GP17), or at RFs 0.12 and/or 0.6 (e.g. GP4). The two latter zones are 
absent in ginkgo. Under UV 366 nm prior to derivatisation (Fig. 1), red zones due to chlorophylls 
are seen in GBL. Additionally, GBL and GBE show a blue fluorescent zone at the position of 
chlorogenic acid, characteristic of ginkgo. Four products lacked this zone (e.g. GP4 and GP7) and 
other four products showed it, but fainter than GBL and GBE. Under UV 366 nm after 
derivatisation 1 (Fig. 1), twenty products showed an intense yellow zone at the position of quercetin 
(e.g. GP4 and GP5) and sometimes faint zones in the rest of the fingerprint (e.g. GP17).
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Fig. 1. HPTLC fingerprints of reference standards, ginkgo leaf and extract, sophora fruit, sophora 
flower buds, buckwheat herb and different cases of adulterations of ginkgo products under different 
detection modes. Track 1: genistein; SST: system suitability test (rutin, chlorogenic acid, and 
quercetin with increasing RF values); GBE: ginkgo leaf refined dry extract; GBL: ginkgo leaf; SJfr: 
Sophora fruit; SJfl: Sophora flower bud; BWH: Buckwheat herb; GP: ginkgo product.
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Eight products lacked zones characteristic of ginkgo and showed mainly a zone due to rutin (e.g. 
GP14). One sample contained only 5-hydroxy tryptophan (GP7) as shown previously. One sample 
(GP3) showed an additional blue zone between RFs 0.6 and 0.7. Sixteen samples showed additional 
green zones between RFs 0.2 and 0.3 (e.g. GP17, GP4 and GP3) most of the time combined with 
high levels of quercetin. Of the five samples labelled as containing ginkgo leaf, two yielded 
fingerprints similar to that of GBE, while three corresponded to GBL, but the zones were less 
pronounced. 
Based on the identification results, it was concluded that many of the analysed products seemed to 
have quality problems, including adulteration. In addition, the intensity of some fingerprints was 
lower than expected. To confirm the hypothesis that some of the products had less extract than 
declared, their total flavonoids content was evaluated.
3.1.  HPLC analysis of flavonoids in ginkgo products according to the USP
The content of flavonol glycosides was determined in fifty-three ginkgo products (GP). Five 
products were not analysed by HPLC due to limited amount of sample available. The percentage 
of flavonoids was calculated from the content of the corresponding aglycones obtained after 
hydrolysis, which are quercetin (Q), kaempferol (K), and isorhamnetin (I). Acceptable contents of 
flavonoids, expressed as flavonol glycosides, were 22.0%-27.0% for the extract, and not less than 
0.5% for the leaves. Furthermore, the peak area ratios of K/Q (required ≥ 0.7) and I/Q (required ≥ 
0.1) were calculated for the products containing extract, as described in the USP powdered ginkgo 
extract monograph. Forty-four samples that declared to contain extract were also analysed for their 
content of rutin and quercetin, based on the method specified in the USP. Acceptable contents prior 
to hydrolysis were ≤ 4% for rutin and ≤ 0.5% for quercetin (see Table S3; supplementary 
information).
The investigated products fall into five categories according to their claims: refined extracts with 
declaration of total flavonoid content, refined extracts without declaration, mixture of extract and 
additional ingredient, other extracts, and products based on dried leaves. 
Of the thirty-eight products containing refined extract with a declaration of flavonoid content, 
thirty-four were analysed for their flavonol glycosides content. Of those, twenty-seven contained 
the amount of flavonol glycosides declared on their labels and twenty-one complied with the K/Q 
and I/Q peak ratios. Six products had less than 22% of total flavonoids and one had more than 
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27%. Regarding the rutin and quercetin contents of those thirty-four products, four had more than 
4% of rutin and twenty-two had more than 0.5% of quercetin. Thus, GP20, 36-43 and 59 were the 
only products of this group compliant with the USP specifications concerning HPTLC fingerprint, 
flavonol glycosides content by HPLC, K/Q and I/Q ratios and HPLC limit test of rutin and 
quercetin. 
Eight of the nine products containing refined extract without declaring the flavonoid content were 
analysed. All of them had less than 22.0% of flavonol glycosides by HPLC. Of those, two had 
more than 4% of rutin and five had more than 0.5% of quercetin.
Of the five products that declared to contain extract mixed with other ingredients, four were 
analysed. They declared to contain either rutin, buckwheat, or ginkgo leaf. The products that 
contained additional rutin or buckwheat had more than 27.0% of flavonol glycosides, yet are 
compliant with their label claims.
Of the two products containing other type of extracts, both had less than 22.0% of flavonol 
glycosides as determined by HPLC. Finally, all five products declaring to contain ginkgo leaf 
complied with the total flavonoid content for the leaf (NLT than 0.5%). 
In general, most of the products that were compliant with the total flavonoids assay had weak 
fingerprints by HPTLC and/or intense zones at the positions of quercetin or rutin and/or additional 
zones. To properly detect addition of rutin and/or quercetin, a supplementary HPLC test is required. 
Nevertheless, results of the HPLTC ID method pointed to quality issues in the same samples as the 
combined HPLC tests. 
In this context, our goal was to evaluate, whether the HPTLC fingerprint, obtained with the ID 
method, can also be used as tool to determine the purity of ginkgo products by detecting the 
presence of adulterants. 
3.2.  HPTLC analysis of ginkgo products
In the next steps of the investigation, first a literature review was performed to identify possible 
adulterants. Then, their HPTLC fingerprints were compared with those of GBL and GBE. 
Thereafter, physical mixtures of GBL and adulterants were analysed. It was evaluated whether the 
HPTLC ID method is capable of distinguishing the adulterants from ginkgo and what their 
respective detection limits were in mixtures. Finally, the HPTLC ID method was evaluated for 
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suitability to verify compliance with the USP HPLC limit tests for rutin and quercetin. In that step, 
different detection modes and derivatisation reagents were investigated.
Samples of sophora fruit and flower bud, and buckwheat were individually analysed using the 
HPTLC ID method and their fingerprints were compared to those of GBE extract and GBL (Fig. 
1).
Under UV 366 nm after derivatisation, sophora fruit featured several unique greenish zones in the 
lower half of the chromatogram, a yellow zone at the position of rutin and a faint greenish zone at 
the position of quercetin, kaempferol, and isorhamnetin. The fingerprint of sophora flower bud was 
comparatively rich in rutin and quercetin, and contained other flavonoids and phenolic compounds 
(faint zones). Its fingerprint pattern was somewhat similar to that of the GBE. Buckwheat also 
showed an intense zone at the position of rutin and another blue fluorescent zone between RFs 0.4 
and 0.5. Other reddish and yellowish zones were observed in the upper half of the chromatogram. 
Other individual characteristics were observed under UV 254 nm for each sample. 
For the investigation of admixtures, physical mixtures of 1, 3, 5, 10, 15, and 20% each of sophora 
fruit, sophora flower bud, and buckwheat powdered drugs with 99, 97, 95, 90, 85, and 80% of 
ginkgo leaf were prepared.
3.2.1. Admixture of buckwheat herb (Fagopyrum sp.)
To visualise admixtures with buckwheat, different detection modes were evaluated. Under UV 366 
nm prior to derivatisation (Fig. S5), a faint reddish zone was seen in the middle of the 
chromatogram in the ginkgo leaf spiked with 15% buckwheat. This zone was absent in ginkgo leaf. 
One sample (GP9), which listed buckwheat as an ingredient, showed similar reddish zones. In this 
respect, the product cannot be considered as adulterated. Nevertheless, the same sample was found 
to contain sophora flower bud. 
3.2.2. Admixture of sophora flower bud
When sophora flower bud was mixed with ginkgo leaf (Fig. 2), the amounts of rutin and quercetin 
increased. However, with this method it was not possible to link these higher levels of rutin and 
quercetin to bulk chemicals or a herbal drug. In the absence of specific markers to detect the 
presence of sophora flower bud, alternative derivatisation 3 was introduced: following 
derivatisation with NP reagent and visualising the image under UV 366 nm, the plate was 
derivatised with anisaldehyde reagent and documented under white light. Because anisaldehyde 
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reagent cannot be used subsequently to PEG reagent (used in derivatisation 1 of the ID method), 
that derivatisation reagent had to be eliminated (derivatisation 2) (Table 1). Detection of flavonoids 
is not significantly altered by PEG (Fig. S6). However, subsequent use of anisaldehyde instead 
provided an extra set of data without the need to repeat the chromatography. 
Fig. 2. HPLTC fingerprints of physical mixtures of ginkgo leaf and sophora flower bud, and examples of 
adulterated products. GBL: ginkgo leaf, SJfl: sophora flower bud. Track 1: 100% SJfl, track 8: 100% GBL, 
tracks 2-8: mixtures of SJfl and GBL, tracks 9-10: products adulterated with SJfl.
The chromatogram of ginkgo leaf spiked with 5% of sophora flower bud showed two purple zones 
above and below the zone due to rutin, combined with an elevated amount of rutin. When the 
ginkgo products were tested with this detection, two samples (GP29 and 17) presented a pattern 
similar to that described above, indicating adulteration with sophora flower bud. 
3.2.3. Admixture of sophora fruit
Avula et al. (2015) and Wohlmuth et al. (2014) stated that genistein is a characteristic constituent 
of sophora fruit and can be used as a marker to detect adulteration with this drug. However, in 
the HPTLC ID method genistein migrated close to the solvent front and was barely detected after 
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derivatisation under UV 366 nm (Fig. 1). Under UV 254 nm prior to derivatisation, genistein was 
detectable (Fig. 1) but co-eluted with quercetin. 
In Fig. 3, the fingerprint of ginkgo leaf containing 1% of sophora fruit after derivatisation, showed 
a green zone between RFs 0.1 and 0.2, which was absent in 100% ginkgo leaf. Under UV 254 nm 
prior to derivatisation one quenching zone between RFs 0.5 and 0.6 was seen in the sample spiked 
at 1%. A second zone between RFs 0.1 and 0.2 was observed in the sample spiked at 3%. The 
described zones are detected in 17 of the 59 products. Therefore, these three zones can be used to 
identify the presence of 1% or more of sophora fruit in mixtures with ginkgo leaf. 
Fig. 3. HPLTC fingerprints of the physical mixtures of ginkgo leaf and sophora fruit, and examples 
of adulterated products. Track 1: 100% SJfr, track 8: 100% GBL, tracks 2-8: mixtures of SJfr and 
GBL, tracks 9-25: products adulterated with SJfr.
3.2.4. Limit test for rutin
Forty-six products declaring to contain ginkgo extract, were investigated for compliance with the 
USP limit for rutin by the HPTLC ID method using a reference solution containing rutin standard 
at 0.4 mg/mL, equivalent to 4% of the extract weight. Percentage values of rutin were calculated. 
Results are shown in Fig. 4 and Table S2. Eight samples (GP14, 17, 23, 26, 32, 45, 49 and 54) 
exceeded the 4% limit. Of those, samples GP14, 23, 32, 45 49 and 54 seemed to contain mainly 
rutin, because they showed only a yellow zone at the position of rutin and lacked other zones 
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characteristic of ginkgo. Samples GP17 and 26 were found to be adulterated with sophora flower 
bud and fruit, and consequently showed an amount of rutin above the accepted level. One sample 
that contained mainly rutin (GP 30) complied with the limit test and had a low content of flavonol 
glycosides. 
Fig. 4. Comparison of the results of the limit test for rutin in relation to the refined extracts 
contained in the products, obtained by the HPTLC ID method and by HPLC. Dashed line: 
maximum content of rutin (4%) according to the USP powdered ginkgo extract monograph. * Not 
analysed by HPLC due to the limited amount of sample.
The HPTLC data were compared to those of HPLC. Results were in agreement regarding samples 
passing or failing the limit test. In six samples, the values from HPLC were considerably higher 
than those obtained by HPTLC. This was due to the limited dynamic range of the HPTLC detection 
resulting in saturation. Values below 4% were very similar with both methods. Thus, the HPTLC 
ID method can substitute the HPLC method in the limit test for rutin prescribed in the USP 
powdered ginkgo extract monograph.
3.3. Limit test for quercetin
The compliance to the limit test for quercetin was also investigated in the forty-six products using 
the HPTLC ID method. A ginkgo extract from HWI with known quercetin content was prepared 
to contain 0.5% of quercetin in the solution. This solution representing the samples in which 
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quercetin is co-eluting with other zones (Fig. 1) was used instead of a standard solution of 
quercetin. After conversion of the image under UV 366 nm after derivatisation with NP into peak 
profiles, the height of the yellow/greenish peak at RF 0.9 (corresponding to Q/K/I and other zones) 
in the products was compared against that of the standard. Results are shown in Fig. 5. 
Of the investigated products, only eighteen complied with the limit test for quercetin. Of those, 
seven contained mainly rutin (GP 14, 23, 30, 32, 45, 49 and 54) and one was adulterated with 
sophora fruit (GP26). Only ten had a fingerprint similar to GBE (GP 20, 36-43 and 59) (Fig. S1 
and Fig. S2). This result was in agreement with the HPLC limit test for quercetin (Fig. 5). One 
product (GP54), which was found to be compliant after HPTLC analysis, was, however, found to 
contain more than 0.5% of quercetin when analysed by HPLC. Nevertheless, this sample was not 
compliant with the rutin limit test, and would thus fail in quality control.
Fig. 5. Comparison of the quercetin zone intensity, expressed in AU, of forty-six ginkgo products 
containing refined extract with GBE representing 0.5% of quercetin. 
An additional reversed phase HPTLC method (Table 1), which improves the separation of 
quercetin from the other two aglycones, was used for confirmation of results of the limit test for 
quercetin in all samples (Fig. S7). Peak profiles were generated from images under UV 366 nm 
obtained after derivatisation with NP and PEG reagents. The quercetin percentages were 
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determined against a quercetin standard solution equivalent to 0.5% of the extract weight (Fig. 6 
and Table S2). Results were in accordance to those obtained by HPLC.
The data using HPLC and HPLTC ID methods for the quercetin limit were comparable in 98% of 
the cases, and when combined with the other data, the HPTLC results lead to the same conclusion 
as those obtained by HPLC. Thus, the HPTLC ID method can be used instead of the USP HPLC 
method for determining the limit of quercetin. Samples with borderline results by HPTLC may be 
evaluated with other methodologies (HPLC or reversed phase HPTLC) for confirmation. 
Fig. 6. Comparison of the results of the limit test for quercetin in relation to the refined extracts 
contained in the products, obtained by HPTLC reversed phase method and by HPLC. Dashed line: 
maximum content of quercetin (0.5%) according to the USP powdered ginkgo extract monograph. 
* Not analysed by HPLC due to the limited amount of sample.
3.4.  HPTLC decision tree
For better understanding of the significance of the proposed HPTLC method for the routine quality 
control of ginkgo products a decision tree has been designed (Fig. 7). It shows the sequence of 
interpretation of the fingerprints obtained with the different detections after a single HPTLC 
analysis. Thus, this decision tree can help the analyst to evaluate whether samples have the correct 
identity and whether they contain or not adulterants.
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Fig. 7. Decision-tree about how to best perform comprehensive HPTLC fingerprinting for 
identification and detection of adulterations in ginkgo products. 
4. Conclusion
This work provides a new pragmatic and cost-efficient approach to the quality control of ginkgo 
products, based on the “comprehensive HPTLC fingerprinting” concept. A single HPTLC analysis, 
carried out during identification, can also be used to detect adulteration with sophora fruit, sophora 
flower bud, buckwheat herb, quercetin, or rutin. Peak profiles generated from the images can be 
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used to perform a limit test for quercetin and rutin without the need of an additional analysis if 
reference standards are applied at suitable levels. In this case HPTLC and HPLC data lead to the 
same conclusion. However, the HPTLC method cannot be considered valid for rutin or quercetin 
quantification purposes out of the limit test, which is only aimed to give a pass/fail decision.
Only eleven of the investigated fifty-nine GB products comply with specifications of the USP for 
identity, limits on rutin and quercetin, and content of total flavonoids. To the best of our 
knowledge, this is the largest study performed on commercial ginkgo products. Such a large 
percentage of poor quality and clearly adulterated products calls for quality control measures at 
earlier stages and throughout the value chains from the raw material to finished products (Booker 
and Heinrich 2016). For legitimate companies wanting to produce good quality products, HPTLC 
is able to provide important information concerning raw material acquisition, product 
development, the control of intermediate processing steps and final product compliance. However, 
much of the poor quality appears to be either deliberate (such as in the case of adulteration) or 
arising through an insufficient understanding of the manufacturing processes. In this context 
HPTLC can be a valuable tool used to highlight poor practice within the industry, provide evidence 
to regulatory bodies and ultimately to disseminate a greater awareness of product differences to 
the general public.  
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